Clorox executive awarded shares, now holds 32,203
Clorox Co. executive Stacey Grier reported receiving 9,913 shares of common stock on October 3, 2025, in settlement of a 2022 Performance Unit Grant valued at $122.25 per share, with part of the award deferred under the company’s Stock Incentive Plan.
Rhea-AI Filing Summary
Clorox Co. executive Stacey Grier reported receiving 9,913 shares of common stock on October 3, 2025, in settlement of a 2022 Performance Unit Grant valued at $122.25 per share, with part of the award deferred under the company’s Stock Incentive Plan. On the same date, 1,032 shares were withheld by the company to satisfy tax obligations related to vesting awards. After these transactions, Grier directly owns 32,203 shares of Clorox common stock, including 1,004 acquired through the plan’s dividend reinvestment feature.
Positive
- None.
Negative
- None.
Insights
Vesting shows routine executive compensation settlement with tax withholding.
The settlement of a 2022 performance unit on 10/03/2025 converted to 9,913 common shares, and the reporting person elected to defer receipt under the plan, which is a common governance practice to align long-term incentives.
Withholding of 233 and 799 shares for tax obligations reduced immediate share count; monitor any future deferral distributions or additional elections during subsequent vesting cycles over the next 12 months.
Net change reflects vesting plus tax-withholdings and dividend reinvestment.
The filing shows the net effect: a 9,913-share settlement offset by share withholding for taxes and a final beneficial holding of 32,203 shares. The inclusion of 1,004 dividend-reinvested shares is explicitly noted.
Key items to watch are the timing of deferred distributions and how future tax-withholding practices affect outstanding insider holdings in the next 12 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 9,913 | $122.25 | $1.21M |
| Exercise Price or Tax Liability | Common Stock | 233 | $122.25 | $28K |
| Exercise Price or Tax Liability | Common Stock | 799 | $122.25 | $98K |
Footnotes (4)
- F1. Settlement of 2022 Performance Unit Grant that vested 10/3/25, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan.
- F2. Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units.
- F3. Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock.
- F4. Includes 1,004 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
Key Figures
Key Terms
Performance Unit Grant financial
2005 Stock Incentive Plan financial
dividend reinvestment feature financial
performance stock units financial
restricted stock financial
FAQ
What insider transaction did CLX executive Stacey Grier report?
What was the nature of Stacey Grier’s CLX stock award?
Does Stacey Grier’s CLX Form 4 involve a trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.